Real-World Evidence & Data Solutions

A Growing Need for Real-World Evidence

Evidence of safety, effectiveness, and value is necessary to achieve successful market access and product uptake. In addition to robust early development clinical trial programs, payers, patients, physicians, and caregivers demand evidence of benefits and risks in a real-world setting. Once commercialized, product insights from real-world data are critical to confirming and updating your market strategy.

Evidera’s multidisciplinary team of data scientists, epidemiologists, and statisticians offer a host of fit-for-purpose solutions to address your most challenging research questions. When appropriate, we also leverage the global footprint, therapeutic expertise, and deep clinical development experience of PPD to execute hybrid retrospective and prospective studies.

We Can Help You

Delineate the natural history and course of disease (e.g., incidence, prevalence, standard(s) of care)
Determine unmet clinical and humanistic needs by characterizing the burden of illness
Collect and analyze robust data from rare disease populations
Quantify real-world product-specific and/or comparative safety, effectiveness, treatment patterns, adherence, and other outcomes
Evaluate country-specific treatment patterns, quantify associated costs of care, and populate health economic models
Evaluate the safety and benefit-risk profile of a therapy to support regulatory decision-making
Measure your product’s key performance indicators and better understand the market landscape you compete in to confirm or adjust your market strategy

We offer you

Database Study Designs

Analysis of real-world data (RWD) from secondary data sources, such as claims or EMR data, to understand a host of questions around how a product performs in the real-world setting

Hybrid Study Designs

Enrich study design through a strategic blending of real-world evidence (RWE) using secondary databases and data collection studies to drive efficiencies and accelerate timelines

Trial Augmentation

Use external comparators generated from retrospective/observational real-world data to make indirect comparisons with the trial cohort or to serve as real-world benchmarks

Learn More

Data Science Applications

The seamless integration of data science and novel data to generate advanced health analytics (e.g., natural language processing and machine learning to mine social media for condition mapping and patient voice, deploying machine learning for event prediction and predictor discovery, and leveraging wearables and mHealth for remote monitoring and data collection)

Watch our recent social media webinar

LiveTracker^®

Cloud-based platform delivering dynamic, real-time syndicated data to monitor and anticipate market changes for your commercialized products

Learn More

OncoLocator™

Syndicated patient data collection via an interactive dashboard providing real-time understanding of treatment patterns in common cancers

Learn More

Real-World Data Networks

Our 30+ year global network of over 2.2 million HCPs
Our innovative EMR technology-enabled site network (REWARD)

Integrated Evidence Generation Planning

Strategic guidance to help determine the best approaches for generating the right evidence to improve your product’s value proposition and market access potential

Virtual/Decentralized Studies

Placing patients at the center of a trial and allowing them to participate more easily to enable the collection of rich, real-world data

Read a recent case study

Deep Data Insights

Evidera can critically assess the available databases to identify those that will yield the best information to address your research needs. We offer a breadth of experience and a deep understanding of 100+ diverse data sources including registries, electronic medical records (EMRs), claims data, patient generated data (e.g., wearables, mobile health, etc.) from more than 20+ countries in North America, Europe, Asia Pacific, and other regions (e.g., Latin America, Middle East, Australasia etc.)

Additionally, we have direct access to our own data source – LiveTracker^® – which provides robust treatment data through our network of 2.2 million healthcare providers (HCPs) across 55+ countries.

When suitable sources of secondary data are not available or are inadequate, we can design and execute hybrid study approaches or prospective data collection that result in tailored, fit-for-purpose data. Learn more about our non-interventional studies.